Literature DB >> 25014280

[Adaptation of the process of prenatal care in accordance with criteria established by the Humanization of Prenatal and Birth Program and the World Health Organization].

Rúbia Bastos Soares Polgliane1, Maria do Carmo Leal2, Maria Helena Costa Amorim1, Eliana Zandonade1, Edson Theodoro dos Santos Neto1.   

Abstract

The scope of this article is to assess the adequacy of the process of prenatal care provided to users of the Unified Health System in the city of Vitória, in accordance with criteria established by the Humanization of Prenatal and Birth Program (PHPN) and the World Health Organization (WHO). The information on the prenatal care records of 360 pregnant women interned in public hospitals in the city at the time of delivery were assessed. The information was collected, processed and submitted to descriptive statistical analysis for calculations of absolute and relative frequencies and confidence intervals. None of the pregnant women were given entirely appropriate prenatal care in accordance with WHO criteria, and only 5% of pregnant women received prenatal care in line with PHPN. 44.7% of the women did not begin prenatal care until the 4th month. With respect to conducting technical procedures in the appointments, the main emphasis was on checking maternal weight (95.0%) and blood pressure (95.6%). The results indicate the need for a review of the number of prenatal appointments in the municipality and the adoption of strategies to meet the minimum criteria that need to be performed during prenatal care in public health services.

Entities:  

Mesh:

Year:  2014        PMID: 25014280     DOI: 10.1590/1413-81232014197.08622013

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  1 in total

1.  Prenatal evaluation in primary care in Northeast Brazil: factors associated with its adequacy.

Authors:  Esther Pereira da Silva; Antônio Flaudiano Bem Leite; Roberto Teixeira Lima; Mônica Maria Osório
Journal:  Rev Saude Publica       Date:  2019-05-06       Impact factor: 2.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.